Keith Stewart, M.B., Ch.B.
Keith Stewart, M.B., Ch.B., conducts translational research in multiple myeloma. This includes both basic and clinical research to identify novel targets for therapy in multiple myeloma.
Dr. Stewart's research is supported by the National Cancer Institute, Multiple Myeloma Research Foundation, and Leukemia & Lymphoma Society, as well as by partnerships with the pharmaceutical industry for clinical trials.
Dr. Stewart's research can be divided into three broad categories:
Significance to patient care
Dr. Stewart and his colleagues are conducting research that has direct relevance to patient care, as they are discovering markers for prognosis and drug responsiveness, understanding what makes patients resistant to drugs, and applying this knowledge in the clinic with clinical trials exploring novel therapeutics in multiple myeloma, amyloidosis and other blood cancers.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.